Found: 10
Select item for more details and to access through your institution.
SOHO State of the Art Updates and Next Questions: Novel Therapeutic Strategies in Development for Myelofibrosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 4, p. 219, doi. 10.1016/j.clml.2022.12.014
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions: New Targetable Pathways in Chronic Lymphocytic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 4, p. 232, doi. 10.1016/j.clml.2023.01.009
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions | Hyper-CVAD in 2022: Lessons Learned and New Approaches.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 4, p. 238, doi. 10.1016/j.clml.2023.01.013
- By:
- Publication type:
- Article
Disease Monitoring In Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 4, p. 244, doi. 10.1016/j.clml.2023.01.005
- By:
- Publication type:
- Article
Total Body Irradiation Versus Chemotherapy Conditioning in Pediatric Acute Lymphoblastic Leukemia Patients Undergoing Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 4, p. 249, doi. 10.1016/j.clml.2023.01.004
- By:
- Publication type:
- Article
Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade Lymphomas.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 4, p. 259, doi. 10.1016/j.clml.2023.01.010
- By:
- Publication type:
- Article
The Dynamics of Financial Toxicity in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 4, p. 266, doi. 10.1016/j.clml.2023.01.008
- By:
- Publication type:
- Article
Retrospective Review of Outcomes of Multiple Myeloma (MM) Patients With COVID-19 Infection (Two-Center Study).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 4, p. 273, doi. 10.1016/j.clml.2023.01.006
- By:
- Publication type:
- Article
Hyperfractionated Cyclophosphamide and Dexamethasone Alone or in Combination with Daratumumab and/or Carfilzomib for the Treatment of Relapsed or Refractory Multiple Myeloma: A Single-Center Retrospective Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 4, p. 279, doi. 10.1016/j.clml.2022.12.004
- By:
- Publication type:
- Article
Whole-Exome Sequencing Revealed the Mutational Profiles of Primary Central Nervous System Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 4, p. 291, doi. 10.1016/j.clml.2023.01.003
- By:
- Publication type:
- Article